Matt, Author at European Medical Journal - Page 166 of 212

Implementation of Salt-Reduction Policy Could Have Massive Benefits

Substantial health and economic gains could result from the implementation of the U.S. FDA’s proposed voluntary salt policy, according to an analysis…

Belgium-Based Start up Minze Health Launches Innovative Tool for Diagnosis and Monitoring of Patients with Voiding Disorders

A patient friendly tool for diagnosis and monitoring of men, women and children with voiding disorders; set for commercialization after obtaining ISO and…

Increased Physical Activity Reduces Genetic Risk of Heart Disease

Higher fitness levels are associated with a lower risk of heart attacks and stroke, including among people who are genetically predisposed to heart…

Very Low-Protein Diet Can Delay Dialysis Initiation by a Year

Chronic kidney disease (CKD) patients receive a number of benefits from a very low-protein diet supplemented with ketoanalogues, according to research…

Mathematical Model Could Improve Treatment for Abdominal Aortic Aneurysms

Treatment of abdominal aortic aneurysms (AAA) could be enhanced following the development of a mathematical model that can help prevent movement of the…

Genetic Analysis Could Lead to Simplified Test for Diagnosing Growth Hormone Deficiency

Diagnosing growth hormone deficiency (GHD) in children could be undertaken much more quickly and effectively following the development of a new test by…

The 70th Anniversary Since the Discovery of the Lupus Erythematosus Cell: An Interview with Paul Howard of Lupus UK

This year marks a major milestone in the history of lupus disease: it is the 70th anniversary since the haematologist Malcolm Hargraves and colleagues…

This April 2018, EMJ Supports...

This April, EMJ has proudly showcased its support for World Hemophilia Day, Bowel Cancer Awareness Month, and Allergy Awareness Week.

Skin Bacteria Can Protect Against Cancer

Skin bacteria could provide protection from several types of cancer, according to the results of a new study carried out at the University of California…

Approval of Interleukin-23 Antagonist for the Treatment of Plaque Psoriasis

Psoriasis treatment could be revolutionised following the recent approval of an interleukin-23 antagonist, known as tildrakizumab, by the U.S. Food and…